TRENTAL (Pentoxifylline) in Vascular Disease: Innovations and New ApplicationsDE SANCTIS, Maria Teresa; INCANDELA, Lucrezia; RAMASWAMI, Ganesh et al.Angiology. 2002, Vol 53, issn 0003-3197, 55 p., SUP1Serial Issue

Treatment of vascular retinal disease with pentoxifylline: A controlled, randomized trialINCANDELA, L; CESARONE, M. R; BELCARO, G et al.Angiology. 2002, Vol 53, pp 31-34, issn 0003-3197, SUP1Article

Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial. Walking distance and microcirculationDE SANCTIS, M. T; CESARONE, M. R; AGUS, G et al.Angiology. 2002, Vol 53, pp 7-12, issn 0003-3197, SUP1Article

Treatment of vascular inner ear disease with pentoxifylline: A 4-week, controlled, randomized trialINCANDELA, L; CESARONE, M. R; BELCARO, G et al.Angiology. 2002, Vol 53, pp 19-22, issn 0003-3197, SUP1Article

Treatment of severe intermittent claudication with pentoxifylline: A 40-week, controlled, randomized trialCESARONE, M. R; BELCARO, G; VASDEKIS, S et al.Angiology. 2002, Vol 53, pp 1-5, issn 0003-3197, SUP1Article

Treatment of vascular inner ear disease in vascular patients with pentoxifylline: A controlled, randomized trialCESARONE, M. R; INCANDELA, L; BELCARO, G et al.Angiology. 2002, Vol 53, pp 23-26, issn 0003-3197, SUP1Article

Treatment of venous ulcers with pentoxifylline: A 6-month randomized, double-blind, placebo controlled trialBELCARO, G; CESARONE, M. R; NICOLAIDES, A. N et al.Angiology. 2002, Vol 53, pp 45-47, issn 0003-3197, SUP1Article